Skip to main content

Table 1 Clinicopathologic characteristics according to pre-sarcopenia status

From: Prognostic role of pre-sarcopenia and body composition with long-term outcomes in obstructive colorectal cancer: a retrospective cohort study

 

Non-pre-sarcopenia (N = 143)

Pre-sarcopenia (N = 71)

P

Sex, male (%)

75 (52.1)

51 (70.8)

0.008

Age (years), > 70 (%)

29 (20.1)

21 (29.2)

0.138

Location (%)

  

0.958

 Right

32 (22.2)

16 (22.2)

 

 Left

94 (65.3)

46 (63.9)

 

 Rectum

18 (12.5)

10 (13.9)

 

Preoperative CEA, ≥ 5 (%)

55 (40.4)

26 (40.0)

0.952

Neutrophil lymphocyte ratio, ≥ 5 (%)

54 (76.1)

17 (23.9)

0.932

ASA (%)

  

0.466

 I

42 (29.2)

18 (25.0)

 

 II

91 (63.2)

46 (63.9)

 

 III

11 (7.6)

7 (9.7)

 

 IV

0 (0.0)

1 (1.4)

 

Operation methods (%)

  

0.530

 Laparoscopy

57 (39.6)

23 (31.9)

 

 Open

75 (52.1)

43 (59.7)

 

 Conversion

12 (8.3)

6 (8.3)

 

Stage (%)

  

0.092

 II

48 (33.3)

16 (25.0)

 

 III

96 (66.7)

56 (77.8)

 

CONUT score

2.6 ± 2.2

3.2 ± 2.3

0.181

LN harvest

27.4 ± 14.0

26.8 ± 15.1

0.781

Tumor size (cm)

5.5 ± 2.1

5.6 ± 2.2

0.791

Lymphatic invasion, Yes (%)

92 (63.9)

44 (61.1)

0.690

Vascular Invasion, Yes (%)

22 (15.3)

13 (18.1)

0.601

Perineural invasion, Yes (%)

52 (36.1)

28 (38.9)

0.690

Differentiation (%)

  

0.840

 Well

9 (6.3)

4 (5.6)

 

 Moderate

125 (86.8)

63 (87.5)

 

 Poor

10 (6.9)

5 (6.9)

 
  1. CEA carcinoembryonic antigen, ASA American Society of Anesthesiologist physical status, LN lymph node, CONUT Controlling Nutritional Status